Dr. Daniel B. Vinh, M.D.
ENT (Otolaryngology) (Otolaryngology Physician)
- Medicare participating
At a glance
- Medical school
- Stanford University School of Medicine (2012)
- Years since graduation
- 14
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 143
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Medical school: Stanford University School of Medicine
- 2016Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Otolaryngology Physician primary
IN license 01085724A - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Norton Hospitals, Inc Louisville, KY
- Uofl Health - Jewish Hospital and Mary & Elizabeth Hospital Louisville, KY
- Baptist Health Hardin Elizabethtown, KY
- University of Louisville Hospital Louisville, KY
Medical groups
- University of Louisville Physicians Inc (1,445 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 143
- Services billed
- 329
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 52 | 46 |
| Established patient office or other outpatient visit, 30-39 minutes | 37 | 29 |
| New patient office or other outpatient visit, 45-59 minutes | 30 | 30 |
| Diagnostic exam of voice box using a flexible endoscope | 23 | 23 |
| New patient office or other outpatient visit, 30-44 minutes | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Indianapolis, IN | 30 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Indianapolis, IN | 18 |
| Chlorhexidine Gluconate Other prescribers in Indianapolis, IN | 13 |
| Omeprazole Other prescribers in Indianapolis, IN | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 16 payments worth $1,629 in total to this clinician.
| Kls-martin L.P. | $377 |
|---|---|
| Axogen | $300 |
| Zimmer Biomet Holdings, Inc. | $161 |
| Access Pro Medical, LLC | $144 |
| DePuy Synthes Sales Inc. | $118 |
| Medtronic, Inc. | $116 |
| Acera Surgical, Inc. | $113 |
| Baxter Healthcare | $109 |
| Food and Beverage | $1,629 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $6,133 in research payments for these studies, mostly to the institutions running them.
- TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma
Ascendis Pharma Endocrinology Inc · Terminated · NCT05980598
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.